Brokers Offer Predictions for REGN FY2026 Earnings
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) – Equities research analysts at Cantor Fitzgerald issued their FY2026 earnings per share estimates for Regeneron Pharmaceuticals in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst C. Gould expects that the biopharmaceutical company will post earnings of $26.24 per share for […]
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) – Equities research analysts at Cantor Fitzgerald issued their FY2026 earnings per share estimates for Regeneron Pharmaceuticals in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst C. Gould expects that the biopharmaceutical company will post earnings of $26.24 per share for […]
